Skip to content

Examination of single ingestion of drink containing plant extract. N-17003

Examination of single ingestion of drink containing plant extract. N-17003 - Examination of single ingestion of drink containing plant extract. N-17003

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029931
Enrollment
24
Registered
2017-11-13
Start date
2017-11-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

placebo drink not containing plant extract (single ingestion) Drink containing plant extract in high concentration (single ingestion)-&gt
placebo drink not containing plant extract (single ingestion) -&gt
drink containing plant extract in low concentration (single ingestion) Drink containing plant extract in low concentration (single ingestion)-&gt
drink containing plant extract in high concentration (single ingestion) Drink containing plant extract in low concentration (single ingestion)-&gt

Sponsors

TES Holdings Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1.Healthy adults 2.Person whose body math indexes are from 18.5 or more to 25 less than 25.0 3.Person whose diastolic blood pressures are less than 90mmHg and systolic ones less than 140mmHg. 4.Person who are sensitive to cold. 5.Person who can agree not to ingest specified foods and supplements during the test period.

Exclusion criteria

Exclusion criteria: 1.Persons who have severe allergic disease as rhinitis, atopicdermatitis. 2.Patients with vascular function disorder. 3.Persons who have problems with electrocardiogram test such as arrhythmia. 4.Persons who take medicine. 5.Persons who went to hospital regularly to the medical institution within the past one month. 6.Current smoker . 7.Persons who plan to become participates in the other clinical studies or exam. 8.Person who is judged as unsuitable for the study by the investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
Skin temperature.

Secondary

MeasureTime frame
Subjective evaluation.

Countries

Japan

Contacts

Public ContactRyoma Shimizu

TES Holdings Co., Ltd Administrative Department of Clinical Trials

r.shimizu@tes-h.co.jp+81-3-6801-8480

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026